Cost-effectiveness of hepatitis C virus test-and-treat and risk reduction strategies among men who have sex with men living with HIV in France.

"COMPETING INTERESTS KC has received honoraria for presentations from Gilead outside of this work. VS reports lecture fees from Gilead, Janssen and Viiv outside the submitted work. JG reports personal fees from Merck, grants and personal fees from ViiV healthcare, grants and personal fees from Gilead Sciences, personal fees from Roche, personal fees from AstraZeneca, and personal fees from Janssen, outside the submitted work. SDB has received consultancy fees from Intercept. The remaining authors have nothing to disclose."

"FUNDING This work was supported by the French Agency for Research on AIDS and Viral Hepatitis (ANRS) [grant number 95031]. The ANRS had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript."